ID Source | ID |
---|---|
PubMed CID | 72710734 |
MeSH ID | M0554504 |
Synonym |
---|
d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1->4))-2-deoxy-n1-ethyl-, sulfate (salt) |
etimicin sulfate |
mc6xb22ugq , |
unii-mc6xb22ugq |
d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1->4))-2-deoxy-n1-ethyl-, sulfate |
d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-erythro-hexopyranosyl-(1->4))-2-deoxy-n1-ethyl-, sulfate |
d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-erythro-hexopyranosyl-(1->4))-2-deoxy-n1-ethyl-, sulfate (salt) |
etimicin sulfate [who-dd] |
Q27283842 |
Excerpt | Reference | Relevance |
---|---|---|
" It was found to be a safe alternative for various severe infections." | ( Sub-acute toxicity study of a new aminoglycoside etimicin sulphate in swiss albino mice. Chaudhary, M; Dwivedi, VK; Gupta, A; Payasi, A, 2010) | 0.36 |
Excerpt | Reference | Relevance |
---|---|---|
"This paper describes an improved liquid chromatography method combined with pulsed electrochemical detection for the analysis of etimicin sulfate." | ( Improved liquid chromatography combined with pulsed electrochemical detection for the analysis of etimicin sulfate. Adams, E; Deng, X; Fan, X; Hu, C; Wang, F; Wu, Y; Yuan, Y; Zhang, M; Zhao, W; Zhu, X, 2016) | 0.43 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (16.67%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |